Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon‐α therapy

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Clinical Endocrinology

• Publication date

  1996-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2265.1996.751768.xPMID 8759175
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a.

  1995influential reference
• The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey

  1995cited by this paper
• High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C

  1995cited by this paper
• Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C.

  1995cited by this paper
• Autoimmune hepatitis

  1995cited by this paper
• Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis.

  1995cited by this paper
• Reversible inhibition by interferons alpha and beta of 125I incorporation and thyroid hormone release by human thyroid follicles in vitro.

  1993cited by this paper
• Non-organ specific autoantibodies associated with chronic C virus hepatitis.

  1993cited by this paper
• High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy

  1993cited by this paper
• Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.

  1993cited by this paper
• The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle‐aged women: associations with serum lipids

  1993cited by this paper
• Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C

  1993cited by this paper
• Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa.

  1992cited by this paper
• Transient thyrotoxicosis and persistent hypothyroidism due to acute autoimmune thyroiditis after interleukin-2 and interferon-alpha therapy for metastatic carcinoma: a case report.

  1992cited by this paper
• Autoimmune thyroiditis: predisposition and pathogenesis

  1992cited by this paper
• Thyrotropin receptor antibodies following treatment with recombinant alpha-interferon in patients with hepatitis.

  1991cited by this paper
• Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C.

  1991cited by this paper
• Hepatitis C viraemia in adults with type 2 autoimmune hepatitis

  1991cited by this paper
• Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors.

  1991cited by this paper
• Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process.

  1990cited by this paper
• Treatment of chronic type B hepatitis with recombinant α‐interferon induces autoantibodies not specific for autoimmune chronic hepatitis

  1989cited by this paper
• Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

  1989cited by this paper
• INDUCTION OF HYPERTHYROIDISM BY INTERFERON-α-2b

  1989cited by this paper
• Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

  1989cited by this paper
• TREATMENT OF CHRONIC TYPE-B HEPATITIS WITH RECOMBINANT LEUKOCYTE-ALPHA A INTERFERON - RESULTS OF A PHASE-II TRIAL

  1987cited by this paper
• Immunoregulation in autoimmune thyroid disease.

  1987cited by this paper
• Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon.

  1986cited by this paper
• Primary hypothyroidism associated with interferon therapy of breast cancer.

  1985influential reference
• Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action.

  1985cited by this paper
• Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity.

  1983cited by this paper
• Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

  1981cited by this paper

• Thyroid Autoimmunity and SARS-CoV-2 Infection

  2023cites this paper
• A systematic review and meta-analysis of endocrine-related adverse events associated with interferon

  2022cites this paper
• A retrospective study of prevalence and pattern of international consensus on ANA patterns among patients with hepatitis C virus infection

  2022cites this paper
• Association of interferon-based therapy with risk of autoimmune diseases in patients with chronic hepatitis C virus infection: A population-based Taiwanese cohort study

  2022cites this paper
• Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity

  2022cites this paper
• CRISPR/Cas12a collateral cleavage activity for simple and rapid detection of protein/small molecule interaction.

  2021cites this paper
• Hepatic pathological features in naïve patients with chronic hepatitis C who have developed thyroid disorder

  2021influential citation
• Identification of thyroid hormone/thyroid hormone receptor interaction based on aptamer-assisted protein-induced fluorescence enhancement.

  2021cites this paper
• Thyroiditis

  2021cites this paper
• The interplay between thyroid and liver: implications for clinical practice

  2020cites this paper
• Thyroid dysfunction among chronic hepatitis C patients and its relation to Interferon therapy

  2020cites this paper
• Anticancer Drug-induced Thyroid Dysfunction.

  2020cites this paper
• Thyroid Gland Disorders in Patients with Hepatitis C Virus Infection in Yemen

  2019cites this paper
• Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan

  2019cites this paper
• The role of viral infections in the development of autoimmune diseases

  2019cites this paper
• Infections, genetic and environmental factors in pathogenesis of autoimmune thyroid diseases.

  2018cites this paper
• High prevalence of HCV (GT4)-related TSH abnormality among 13402 Egyptian patients treated with direct acting antiviral therapy

  2018cites this paper
• Additive Value of Thyroid Uptake and Scintigraphy in Diagnosis of Short-Term Thyroid Dysfunction in Hepatitis C Patients Treated With Interferon-α Younis , J 1

  2017cites this paper
• Thyroid Dysfunction in Non-Interferon Treated Hepatitis C Patients Residing in Hepatitis Endemic Area

  2017cites this paper
• Environmental Issues in Thyroid Diseases

  2017cites this paper
• Thyrotoxic graves' disease-induced by interferon-ribavirin therapy in a patient with amiodarone-induced hypothyroidism on thyroxine replacement

  2017cites this paper
• The therapeutic effects of Yongdamsagan-tang on autoimmune hepatitis models.

  2017cites this paper
• EVALUATION OF Β-LACTAM AND AMINOGLYCOSIDES SYNERGISTIC EFFECT ON MULTIDRUG RESISTANT PSEUDOMONAS

  2017cites this paper
• Thyroid Disturbance in Patients with Chronic Hepatitis C Infection: A Systematic Review and Meta-analysis.

  2016cites this paper
• Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report

  2016cites this paper
• Anti-thyroid Antibodies in Patients with HCV Genotype 3a: A Pilot Study

  2016cites this paper
• Autoimmune Thyroid Disease in Patients with Philadelphia-Negative ChronicMyeloproliferative Neoplasms Treated with Interferon-Alpha

  2016influential citation
• Extrahepatic Manifestations of Chronic Hepatitis C Infection: a Review and Update

  2016cites this paper
• Manife s tacio ne s clínicas e inmuno ló gicas as o ciadas a la infe cció n cró nica po r e l virus de la he patitis C

  2016cites this paper
• The role of human parvovirus B19 and hepatitis C virus in the development of thyroid disorders

  2016cites this paper
• Hepatitis C virus infection and thyroid autoimmune disorders: A model of interactions between the host and the environment.

  2016cites this paper
• KASL clinical practice guidelines: management of hepatitis C

  2016cites this paper
• Thyroid dysfunction in chronic viral hepatitis [B and C]; An Egyptian pilot study

  2016cites this paper
• Extra Hepatic Manifestations of Liver Diseases

  2016cites this paper
• Thyroid Peroxidase Antibodies in Non-Interferon Treated Hepatitis C Patients in Pakistan

  2015cites this paper
• Autoantibodies in chronic hepatitis C: A clinical perspective.

  2015cites this paper
• Chapter 54 – Infection and Autoimmune Thyroid Diseases

  2015cites this paper
• FREQUENCY OF THYROID DYSFUNCTION DURING TFT IN INTERFERON AND RIBAVIRIN THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C

  2015cites this paper
• DURING COMBINED PEG-INTERFERON ALPHA-2A AND RIBAVIRIN THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C

  2015cites this paper
• Thyroid disorders and gastrointestinal and liver dysfunction: A state of the art review.

  2015cites this paper
• Prevalence of Anti-Thyroid Peroxidaes Antibodies in Patients with Chronic Hepatitis C Virus Infection

  2015cites this paper
• Potential associations between perihepatic lymph node enlargement and liver fibrosis, hepatocellular injury or hepatocarcinogenesis in chronic hepatitis B virus infection

  2015cites this paper
• Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

  2014cites this paper
• Autoimmune and Neoplastic Thyroid Diseases Associated with Hepatitis C Chronic Infection

  2014cites this paper
• Is an isolated TSH elevation in chronic nonthyroidal illness "subclinical hypothyroidism"?

  2014cites this paper
• KASL clinical practice guidelines: Management of Hepatitis C

  2014cites this paper
• Immunological alterations in hepatitis C virus infection.

  2013cites this paper
• Mixed cryoglobulinemia and thyroid autoimmune disorders.

  2013cites this paper
• Hepatitis C Virus E1E2 co-evolving networks unveil their functional dialogs and highlight original therapeutic strategies

  2013cites this paper
• Thyroid Dysfunction as an Unintended Side Effect of Anticancer Drugs

  2013cites this paper
• Frequency of Thyroid Dysfunctions during Interferon Alpha Treatment of Single and Combination Therapy in Hepatitis C Virus-Infected Patients: A Systematic Review Based Analysis

  2013cites this paper
• Hepatitis C Virus Infection of a Thyroid Cell Line: Implications for Pathogenesis of Hepatitis C Virus and Thyroiditis

  2013cites this paper
• HCV-related autoimmune disorders in HCV chronic infection.

  2013cites this paper
• Chronic hepatitis B with type I diabetes mellitus and autoimmune thyroiditis development during interferon alpha therapy.

  2012cites this paper
• Thyroid Dysfunction in Chinese Patients with Chronic Hepatitis C Treated with Interferon Alpha: Incidence, Long-Term Outcome and Predictive Factors

  2012cites this paper
• Autoimmune manifestations in viral hepatitis

  2012cites this paper
• Morphologic Features of Extrahepatic Manifestations of Hepatitis C Virus Infection

  2012cites this paper
• Iatrogenic Hypothyroidism and Its Sequelae

  2012cites this paper
• Interferon-induced thyroiditis during treatment of chronic hepatitis C.

  2012cites this paper
• [Thyroid and hepatitis C].

  2012cites this paper
• Organ-Specific Autoimmunity in HCV-Positive Patients

  2012cites this paper
• Thyroid Function Abnormalities in Patients Receiving Anticancer Agents

  2012cites this paper
• Extrahepatic Manifestations of Chronic HCV

  2012cites this paper
• Managing adverse effects of interferon-alfa and ribavirin in combination therapy for HCV.

  2012cites this paper
• Immune-Related Disorders and Extrahepatic Diseases in Chronic HCV Infection

  2012cites this paper
• Hepatitis C virus infection and autoimmune diseases

  2012cites this paper
• Environmental triggers of thyroiditis: hepatitis C and interferon-α.

  2011cites this paper
• Pegylated-interferon-α2a in clinical practice: how to manage patients suffering from side effects

  2011cites this paper
• Citokine-induced thyroid disorders

  2011cites this paper
• A meta-analysis of patients with chronic hepatitis C treated with interferon-alpha to determine the risk of autoimmune thyroiditis.

  2011cites this paper
• Descriptive study of incidence of side effects of Pegylated interferon alpha therapy and their relation to age, gender, duration of treatment and type of hepatitis in 50 Iraqi patients.

  2011cites this paper
• Prevalence of thyroid autoantibodies in hepatitis C and hepatitis B infection in China.

  2011cites this paper
• con interferón-alfa para determinar el riesgo de tiroiditis autoinmune

  2011cites this paper
• Thyroid dysfunction and long-term outcome during and after interferon-alpha therapy in patients with chronic hepatitis C.

  2011cites this paper
• Drug-Induced Endocrine Autoimmunity

  2011influential citation
• The influence of interferon alpha on the induction of autoimmune thyroiditis in patients treated for chronic viral hepatitis type C.

  2011cites this paper
• Environmental triggers of thyroiditis: Hepatitis C and interferon-α

  2011cites this paper
• Thyroid dysfunction from antineoplastic agents.

  2011cites this paper
• HLA Status and Antithyroid Autoantibodies in Egyptian Patients with Chronic Hepatitis C Virus Infection

  2011cites this paper
• Management of Hepatitis C Antiviral Therapy Adverse Effects

  2010influential citation
• Hypothyroidism in Noninterferon Treated-HCV Infected Individuals Is Associated with Abnormalities in the Regulation of Th17 Cells

  2010cites this paper
• Thyroid Disorders in Hepatitis C Patients Treated or Not With α-Interferon and Ribavirin

  2010cites this paper
• Avaliação tireoidiana de pacientes infectados pelo vírus da hepatite C: correlação com polimorfismos do gene CTLA4

  2010cites this paper
• Hepatitis C and interferon induced thyroiditis.

  2010cites this paper
• Chapitre 18 – Thyropathies iatrogènes

  2010cites this paper
• hepatite C: correlação com polimorfismos do gene CTLA4

  2010cites this paper
• Cases of interferon-Alpha and Interferon-Beta-Induced Thyroiditis

  2010cites this paper
• Thyroid dysfunction in antiviral therapy of chronic hepatitis C.

  2010cites this paper
• Extrahepatic manifestations associated with chronic hepatitis C infections in Poland.

  2010cites this paper
• Adverse effects of drugs in the treatment of viral hepatitis.

  2010cites this paper
• Systemic abnormalities in liver disease.

  2009cites this paper
• [Pathogenesis of autoimmune thyroid diseases].

  2009cites this paper
• Thyroid dysfunction in patients with chronic hepatitis C: Virus‐ or therapy‐related?

  2009cites this paper
• Extrahepatic Manifestations of Chronic Hepatitis C Infection

  2009cites this paper
• Best Practice & Research Clinical Endocrinology & Metabolism

  2009cites this paper
• Thyroid Autoimmunity and Environment

  2009cites this paper
• Interferon induced thyroiditis.

  2009cites this paper
• Autoimmunity and endocrinology.

  2009cites this paper
• Evolution and predictive factors of thyroid disorder due to interferon alpha in the treatment of hepatitis C.

  2009cites this paper
• Patogênese das doenças tiroidianas autoimunes

  2009cites this paper